Arrayjet are proud to welcome Dr. Joe Keegan, a globally renowned life science entrepreneur to join as non-executive director
- Posted: 03/08/17
We take great pride in announcing a game-changing addition of a new non-executive director, Dr Joseph Keegan to join our team. We are delighted to welcome Dr Joe Keegan, a San Francisco-based biotechnology entrepreneur and one of the most respected leaders in the life sciences industry, as our non-executive director to help drive forward future opportunities and make a transformative impact for the business.
Arrayjet business expansion translates into job creation and fuels next generation bio-printing technology
- Posted: 05/05/17
We are delighted to announce that our recent funding round led by Archangel Investors closed at £650,000. This will drive the expansion of Arrayjet Advance in-house consultancy services, increase our global commercial resources and bring new products to market. We have recently started the process of designing and developing its next generation bio-printing technological solutions with a new product scheduled for launch in 2018.
- Posted: 28/03/17
Arrayjet’s steady growth strategy in North America has been boosted by a contract win for its instrumentation business with The New York Bioscience Cluster, a global pioneer in biomedical research. The Bioscience Cluster facility is located in The Bronx.
- Posted: 23/12/16
Arrayjet is delighted to share it's growing presence in Asia-Pacific by securing a $300,000 deal with Shanghai-based Abmart, a biological and life science technology specialist which is working to industrialise the production of monoclonal antibodies for academic research institutes, biotechnology companies and pharmaceutical laboratories across the globe.